News

Replace is a double-blind, placebo-controlled trial that will randomize approximately 110 patients at over a dozen sites in the US, Canada and Europe. The primary objective is to

For this expansion, Galapagos receives a payment of E2 million cash from GlaxoSmithKline (GSK). This payment is in addition to the existing alliance terms, making the total alliance

According to the company, Actos directly targets insulin resistance, a condition characterized in patients with type 2 diabetes, by improving the sensitivity to insulin mainly in the muscles,

Acetazolamide for injection USP is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma,

The investigational new drug (IND) application seeks permission from the FDA to administer endometrial regenerative cells to 10 patients having specific inclusion or exclusion criteria and will focus

Under the terms of the amendment, Genmab is expected to receive a one-time payment of $4.5m from GlaxoSmithKline (GSK) upon the FDA’s acceptance for review of the filing of the

The company is planning to treat amyotrophic lateral sclerosis (ALS) patients through spinal injections of its stem cells via its patented human neural stem cell technology. ALS is

Dynavax said that it will continue to evaluate regulatory options for the development of Heplisav indicated for adults outside of the US and for the global end-stage renal

Mr Breckenridge was the chairman of the audit committee and served as the audit committee financial expert. He also served as a member of the compensation committee. The